WallStreetZenWallStreetZen

NASDAQ: IMV
Imv Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IMV

Based on 3 analysts offering 12 month price targets for Imv Inc.
Min Forecast
$3.13+34.91%
Avg Forecast
$7.38+217.93%
Max Forecast
$13.00+460.34%

Should I buy or sell IMV stock?

Based on 4 analysts offering ratings for Imv Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMV stock forecasts and price targets.

Forecast return on equity

Is IMV forecast to generate an efficient return?

Forecast return on assets

Is IMV forecast to generate an efficient return on assets?
Company
N/A
Industry
0.14%

IMV earnings per share forecast

What is IMV's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$0.40
Avg 2 year Forecast
-$0.25
Avg 3 year Forecast
-$0.18

IMV revenue forecast

What is IMV's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$5.0M+3,027.97%
Avg 2 year Forecast
$5.0M+3,027.97%
Avg 3 year Forecast
$21.9M+13,594.26%
IMV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMV revenue growth forecast

How is IMV forecast to perform vs Biotechnology companies and vs the US market?
Company
409.37%
Industry
38.69%
Market
9.2%
IMV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMV$2.32$7.38+217.93%Strong Buy
ATHE$3.95$2.00-49.37%Strong Buy
IKT$0.75N/AN/AHold
SNGX$0.45$4.00+788.89%Hold
AEZS$3.74$1.50-59.89%Buy
View Top Biotech Stocks

Imv Stock Forecast FAQ

Is Imv Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: IMV) stock is to Strong Buy IMV stock.

Out of 4 analysts, 3 (75%) are recommending IMV as a Strong Buy, 1 (25%) are recommending IMV as a Buy, 0 (0%) are recommending IMV as a Hold, 0 (0%) are recommending IMV as a Sell, and 0 (0%) are recommending IMV as a Strong Sell.

If you're new to stock investing, here's how to buy Imv stock.

What is IMV's earnings growth forecast for 2023-2025?

(NASDAQ: IMV) Imv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.89%.

Imv's earnings in 2023 is -$29,999,270.On average, 4 Wall Street analysts forecast IMV's earnings for 2023 to be -$3,288,842, with the lowest IMV earnings forecast at -$5,015,485, and the highest IMV earnings forecast at -$2,219,969. On average, 2 Wall Street analysts forecast IMV's earnings for 2024 to be -$2,055,527, with the lowest IMV earnings forecast at -$2,137,748, and the highest IMV earnings forecast at -$2,055,527.

In 2025, IMV is forecast to generate -$1,479,979 in earnings, with the lowest earnings forecast at -$1,479,979 and the highest earnings forecast at -$1,397,758.

What is IMV's revenue growth forecast for 2023-2025?

(NASDAQ: IMV) Imv's forecast annual revenue growth rate of 409.37% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.69%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Imv's revenue in 2023 is $154,014.On average, 1 Wall Street analysts forecast IMV's revenue for 2023 to be $41,110,530, with the lowest IMV revenue forecast at $41,110,530, and the highest IMV revenue forecast at $41,110,530. On average, 1 Wall Street analysts forecast IMV's revenue for 2024 to be $41,110,530, with the lowest IMV revenue forecast at $41,110,530, and the highest IMV revenue forecast at $41,110,530.

In 2025, IMV is forecast to generate $179,981,900 in revenue, with the lowest revenue forecast at $91,923,145 and the highest revenue forecast at $268,040,656.

What is IMV's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: IMV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.14%.

What is IMV's Price Target?

According to 3 Wall Street analysts that have issued a 1 year IMV price target, the average IMV price target is $7.38, with the highest IMV stock price forecast at $13.00 and the lowest IMV stock price forecast at $3.13.

On average, Wall Street analysts predict that Imv's share price could reach $7.38 by Aug 12, 2023. The average Imv stock price prediction forecasts a potential upside of 217.93% from the current IMV share price of $2.32.

What is IMV's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: IMV) Imv's current Earnings Per Share (EPS) is -$3.65. On average, analysts forecast that IMV's EPS will be -$0.40 for 2023, with the lowest EPS forecast at -$0.61, and the highest EPS forecast at -$0.27. On average, analysts forecast that IMV's EPS will be -$0.25 for 2024, with the lowest EPS forecast at -$0.26, and the highest EPS forecast at -$0.25. In 2025, IMV's EPS is forecast to hit -$0.18 (min: -$0.18, max: -$0.17).

What is IMV's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: IMV) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.